# Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients

> **NCT00211952** · PHASE3 · SUSPENDED · sponsor: **Medical University of Gdansk** · enrollment: 542 (—)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** celecoxib

## Key facts

- **NCT ID:** NCT00211952
- **Lead sponsor:** Medical University of Gdansk
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 542 (—)
- **Last updated:** 2005-09-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00211952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00211952, "Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00211952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*